Changes in Selected Renal Function Parameters of Newly Admitted COVID-19 Patients from One Infectious Diseases Center in Ibadan, Nigeria: Indication for Immunopathology

Authors

  • Ganiyu O. Arinola UNIVERSITY OF IBADAN
  • Temitope Oluwagbenga Alonge
  • V. Fabian Edem
  • Adeola Fowotade
  • O.A. Fashina
  • O.I. Akinbola

Abstract

COVID-19 caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) enters the host cells through attachment to the Angiotensin Converting Enzyme-2 receptors (ACE-2) on the host cells. ACE-2 is known to affect renal functions, vasoconstriction and fluid homeostasis. Thus, the impact of SARS-CoV-2 infection on renal functional parameters is worth investigating. Plasma obtained from whole blood samples collected from newly diagnosed COVID-19 patients were analysed for albumin, urea, creatinine, Na, K, Cl and HCO3 using auto analysers. All newly diagnosed patients were immediately admitted for managed at the Infectious Disease Center, Olodo in Ibadan the capital of Oyo State, South Western Nigeria. The results obtained were evaluated to determine the frequency of derangements in the renal parameters of patients with the COVID-19 disease. It was observed that 57.1%, 37.8%, 32.7%, 28.1%, 18.7%, 17.8% and 3.4% of newly diagnosed COVID-19 patients had values of Cl, creatinine, albumin, Na, K, HCO3 and urea respectively outside the reference ranges. While 43.3%, 4.7%, 2.5%, 2.5%, 2.0%, 1.7% and 1.0% of COVID-19 patients had values of Cl, creatinine, Na, K, albumin, Urea and HCO3 respectively above the reference ranges. Of all admitted patients, 33.1%, 30.7%, 25.6%, 16.8%, 16.3%, 13.8% and 1.7% had creatinine, albumin, Na, HCO3, K, Cl and urea values respectively below reference ranges. The changes in renal function parameters of newly diagnosed COVID-19 patients portend that renal failure is imminent in poorly managed COVID-19 patients and this has immunopathology implications during SAR-COV-2 infection.

References

Atlas of tissue renin-angiotensin-aldosterone system in human: A transcriptomic meta-analysis. Sci. Rep. 5, 10.1038/srep10035 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

Betjes MG (2013). Immune cell dysfunction and inflammation in end‐stage renal disease. Nat Rev Nephrol. 9: 255– 265. Crossref CAS PubMed Web of Science®Google Scholar

Bugdayci G, Oguzman H, Arattan HY, Sasmaz G (2015). The use of reference change values in clinical laboratories. Clin Lab. 2015;61(3-4):251-7. doi: 10.7754/clin.lab.2014.140906. CAS Article PubMed PubMed Central Google Scholar

Center for Systems Science and Engineering (2020). Coronavirus COVID-19 global cases.https://www.gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6.

Cha RH, Yang SH, Moon KC et al (2016). A case report of a middle east respiratory syndrome survivor with kidney biopsy results. J Korean Med Sci 31(4):635–640. https://doi.org/10.3346/jkms.2016.31.4.635.CAS Article PubMed PubMed Central Google Scholar

Chan JF, Yuan S, Kok KH et al (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395(10223):514–523. https://doi.org/10.1016/S0140-6736(20)30154-9. CAS Article PubMed PubMed Central Google Scholar

Cheng Y, Luo R, Wang K, et al (2020). Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 97: 829-838.

Chernyak, B.V., Popova, E.N., Prikhodko, A.S. et al (2020). COVID-19 and Oxidative Stress. Biochemistry Moscow 85: 1543–1553. https://doi.org/10.1134/S0006297920120068.

Chu KH, Tsang WK, Tang CS et al (2005) Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int 67(2): 698–705.

Cizmecioglu A, Hilal Akay Cizmecioglu, Mevlut Hakan Goktepe, Ayca Emsen, Celalettin Korkmaz, Fatma Esenkaya Tasbent, Fatma Colkesen, Hasibe Artac (2020). Apoptosis-Induced T Cell Lymphopenia Is Related to COVID-19 Severity . J Med Virol. doi: 10.1002/jmv.26742. PMID: 33331657. DOI: 10.1002/jmv.26742

Flaxman S, Mishra S, Gandy A et al (2020). Report 13: estimating the number of infections and the impact of nonpharmaceutical interventions on COVID-19 in 11 European countries. Imperial College, London. https://doi.org/10.25561/77731

Google Scholar

Hato T, Dagher PC (2015). How the innate immune system senses trouble and causes trouble. Clin J Am Soc Nephrol. 10: 1459– 1469. Crossref CAS PubMed Web of Science®Google Scholar

Hirsch JS, Ng JH, Ross DW, et al.(2020). Acute kidney injury in patients hospitalizedwith COVID-19. Kidney International. 98: 209–218

Huang, C., Wang, Y., Li, X., et al. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet. 20: 30183-30185.

https://doi.org/10.1016/S0140-6736(20)30183-5.

Imai Y., Kuba K., Rao S., Huan Y., Guo F., Guan B. et al (2005). Angiotensin- converting enzyme 2 protects from severe acute lung failure. Nature 436, 112–116 10.1038/nature03712 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

coronavirus disease 2019 (COVID-19): a meta-analysis. J Infect. 2020;81:647-679.

Jin Y, Yang H, Ji W et al (2020). Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses 12(4):372. https://doi.org/10.3390/v12040372 . CAS Article PubMed Central Google Scholar

Kurts C, Panzer U, Anders HJ, Rees AJ. The immune system and kidney disease: basic concepts and clinical implications. Nat Rev Immunol 2013; 13: 738– 753. Crossref CAS PubMed Web of Science®Google Scholar

Li Z, Wu M et al (2020) Caution on kidney dysfunctions of COVID-19 patients. medRxiv. https://doi.org/10.1101/2020.02.08.20021212. Article Google Scholar

Mustafa MI, Abdelrahman H. Abdelmoneim, Eiman M. Mahmoud, Abdelrafie M. Makhawi, "Cytokine Storm in (2013). COVID-19 Patients, Its Impact on Organs and Potential Treatment by QTY Code-Designed Detergent-Free Chemokine Receptors", Mediators of Inflammation, vol. 2020, Article ID 8198963, 7 pages, 2020. https://doi.org/10.1155/2020/8198963

Nehme A., Cerutti C., Dhaouadi N., Gustin M., Courand P., Zibara K. et al. (2015)

Ng JJ, Luo Y, Phua K, et al (2020). Acute kidney injury in hospitalized patients with novel coronavirus in Wuhan, China. Lancet 395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5. CAS Article PubMed PubMed Central Google Scholar

Northwell Nephrology COVID-19 Research Consortium (2020). Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 98: 209-218.

Pan X-W, Da Xu, Zhang H, Zhou W, Wang L-H, Cui X-G (2020). Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med. https://doi.org/10.1007/s00134-020-06026-1. Article PubMed PubMed Central Google Scholar

Rodrigues Prestes T., Rocha N., Miranda A., Teixeira A. and Simoes-e-Silva A. (2017). The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research. Curr. Drug Targets 18, 10.2174/1389450117666160727142401 [PubMed] [CrossRef] [Google Scholar]

Saad MA, Alfishawy M, Nassar M, Mohamed M, Esene IN, Elbendary A (2020). Covid-19 and Autoimmune Diseases: A Systematic Review of Reported Cases. Curr Rheumatol Rev.. doi: 10.2174/1573397116666201029155856. Epub ahead of print. PMID: 33121413

Soos TJ, Sims TN, Barisoni L et al (2020). CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int. 70: 591– 596. Crossref CAS PubMed Web of Science®Google Scholar

Su H, Yang M, Wan C et al (2020). Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. https://doi.org/10.1016/j.kint.2020.04.003. Article PubMed PubMed Central Google Scholar

Tecklenborg J , Clayton D, Siebert S, Coley S.M (2018). The role of the immune system in kidney disease. Clinical and Experimental Immunology. 192(2):142-150. https://doi.org/10.1111/cei.13119

Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG (2012). Into the eye of the cytokine storm. Microbiol Mol Biol Rev 76(1):16–32. https://doi.org/10.1128/MMBR.05015-11. CAS Article PubMed PubMed Central Google Scholar

Wang D, Hu B, Hu C, et al (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323: 1061- 1069.

World Health Organization (2020). Laboratory testing for coronavirus disease (COVID19) in suspected human cases. 2020.

Yang XH, Sun RH, Chen DC (2020). Diagnosis and treatment of COVID-19: Acute kidney injury cannot be ignored] Zhonghua Yi Xue Za Zhi. 100(16):1205–1208

Yatim KM, Lakkis FG (2015). A brief journey through the immune system. Clin J Am Soc Nephrol. 10: 1274–12 81. Crossref CAS PubMed Web of Science®Google Scholar

Zhou F, Yu T, Du R et al (2020). Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3

Published

2021-06-30

Issue

Section

Full Length Research Articles

How to Cite

Changes in Selected Renal Function Parameters of Newly Admitted COVID-19 Patients from One Infectious Diseases Center in Ibadan, Nigeria: Indication for Immunopathology. (2021). Nigerian Journal of Physiological Sciences, 36(1), 11-15. https://ojshostng.com/index.php/njphysiologicalsciences/article/view/1630

Most read articles by the same author(s)